Joseph Group Capital Management Increases Share Position in UnitedHealth Group Incorporated (NYSE:UNH)

Joseph Group Capital Management raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 13.3% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 6,491 shares of the healthcare conglomerate’s stock after purchasing an additional 761 shares during the period. UnitedHealth Group comprises about 1.7% of Joseph Group Capital Management’s holdings, making the stock its 14th largest position. Joseph Group Capital Management’s holdings in UnitedHealth Group were worth $3,306,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Macroview Investment Management LLC boosted its position in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the health care conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the medical conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the last quarter. True Wealth Design LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $31,000. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group in the second quarter valued at approximately $31,000. Finally, Signature Resources Capital Management LLC boosted its stake in UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the medical conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the last quarter. 87.86% of the shares are currently held by hedge funds and other institutional investors.

Indoor activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is available via this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available via this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s shares.

Analyst upgrades and downgrades

A number of research analysts recently weighed in on UNH shares. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17. HSBC lifted their price target on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. TD Cowen raised their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, Baird RW raised UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $614.17, according to MarketBeat.

Read our latest analysis of UnitedHealth Group

UnitedHealth Group’s stock performance

Shares of NYSE UNH opened at $577.10 on Friday. The firm has a 50-day moving average of $575.84 and a 200-day moving average of $519.83. The firm has a market cap of $532.91 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88, and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH – Get Free Report ) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. In the same period last year, the company earned $6.14 per share. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date is Monday, September 16. This represents a dividend of $8.40 on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s payout ratio is currently 51.34%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

Featured stories

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.